BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no cost or financial obligation to you.
Centerspace (NYSE – CSR)
Under the terms of the Merger Agreement, Centerspace will be acquired by Independence Realty Trust, Inc. (NYSE – IRT) in an all-stock transaction whereby Centerspace shareholders will receive 3.800 shares of IRT common stock for each share of Centerspace common stock owned. Holders of common units in Centerspace’s operating partnership will receive 3.800 common units in IRT’s operating partnership. Upon closing, IRT stockholders will own approximately 78% and Centerspace shareholders will own approximately 22% of the combined company’s equity on a fully diluted basis, excluding preferred units. The investigation concerns whether the Centerspace Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/centerspace-nyse-csr/.
Fulcrum Therapeutics, Inc. (Nasdaq – FULC)
Under the terms of the Merger Agreement, Fulcrum Therapeutics will be acquired by Slate Medicines, Inc. Fulcrum stockholders are expected to own 5.0% of the combined company and Slate stockholders are expected to own 95.0% of the combined company. The investigation concerns whether the Fulcrum Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/fulcrum-therapeutics-inc-nasdaq-fulc/.
Weave Communications, Inc. (NYSE – WEAV)
Under the terms of the Merger Agreement, Weave Communications will be acquired by Francisco Partners for $7.40 per share in cash in a deal with an aggregate equity valuation of approximately $650 Million. The investigation concerns whether the Weave Communications Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/weave-communications-inc-nyse-weav/.
Bio-Techne Corporation (Nasdaq – TECH)
Under the terms of the Merger Agreement, Bio-Techne Corporation will be acquired by Merck KGaA for $73.00 per share in cash, representing a total enterprise value of approximately $11.3 billion. The investigation concerns whether the Bio-Techne Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the proposed transaction is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/bio-techne-corporation-nasdaq-tech/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
